The agency approved it based on two Phase III studies showing the drug to be as effective as another combination therapy at improving lung function.

Rouse had presented with symptoms including intense swelling in her legs that she originally thought could be linked to her ...

Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Francis is still on supplemental oxygen and tests showed “initial, mild” kidney failure, the Vatican said, according to the AP, but doctors said the situation is under control and the pope is ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) also has several other treatments in its pipeline, including those aimed at treating diabetes, complex kidney diseases, and other conditions ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price target upped by Royal Bank of Canada from $407.00 to $408.00 in a research note issued to investors on Thursday,Benzinga reports.

The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenodiol, the first ...

If you’re on the fence about investing in Vertex Pharmaceuticals Incorporated ... inaxaplin for the treatment of APOL1-mediated kidney disease which is in single Phase 2; VX-880 and VX-264, treatment ...

25 analysts have shared their evaluations of Vertex Pharmaceuticals VRTX during the ... therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule ...

To that end, Florida Tech has relaunched the underutilized Center for Advanced Manufacturing and Innovative Design as Vertex, a new "applied innovation hub." Rather than function as a traditional ...